article thumbnail

Best Training Methods for the Pharmaceutical Industry

Kitaboo

Pharmaceutical Industry today, is a goldmine of opportunities. The global pharmaceutical market was estimated at approximately $935 billion in 2017 and is bound to reach $1170 billion by 2021. And for a company to succeed, the people who make it, i.e., its employees, should be updated with all the recent developments.

article thumbnail

Can developer productivity be measured? Better than you think

CIO Business Intelligence

Measuring developer productivity has long been a Holy Grail of business. But based on our work with companies from a range of industries, we think we may have figured out a way to do it that could work. Companies in the top quarter delivered four to five times faster revenue growth than those in the bottom quarter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Nvidia became a trillion-dollar company

CIO Business Intelligence

How Nvidia got here and where it’s going next sheds light on how the company has achieved that valuation, a story that owes a lot to the rising importance of specialty chips in business—and accelerating interest in the promise of generative AI.

Company 98
article thumbnail

Alphabet is launching a company that uses AI for drug discovery

The Verge

A new Alphabet company will use artificial intelligence methods for drug discovery, Google’s parent company announced Thursday. The new company, called Isomorphic Laboratories, will leverage that success to build tools that can help identify new pharmaceuticals. Photo by Micah Singleton / The Verge.

Company 130
article thumbnail

Tadataka Yamada, 1945-2021: Pioneer in drug development led global health at Gates Foundation

GeekWire

Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent six years at the Bill and Melinda Gates Foundation as head of global health, died Wednesday morning of natural causes at his home in Seattle. Tadataka “Tachi” Yamada. Twitter Photo via @TachiYamada).

article thumbnail

Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal

GeekWire

(AIS Photo) Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 However, the company’s stock jumped 21% in regular trading Wednesday after Bloomberg News reported it was considering a sale. AstraZeneca paid $1.1 billion in June.

article thumbnail

Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug

GeekWire

Kornberg Lab Image) Cocrystal Pharma , a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The publicly traded company has the green light from regulators for an early-stage clinical trial testing its experimental treatment for COVID-19 and norovirus.

Company 91